Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Ulcerative Colitis Clinical Trials
Ulcerative Colitis clinical trials are recruiting across 195 cities. Here are the cities with the most active studies:
Ulcerative Colitis Trial Phases
80 research organizations are sponsoring ulcerative colitis trials.
About Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory bowel disease that causes inflammation and ulcers in the innermost lining of the colon and rectum. It typically presents with bloody diarrhea, abdominal pain, and urgency. Treatment includes aminosalicylates, corticosteroids, immunosuppressants, and biologics.
Clinical trials are advancing new treatments for ulcerative colitis. Currently, 100 studies are recruiting a combined 249,647 participants across the United States. Research is being conducted by 80 organizations including COPD Foundation, BioDelivery Sciences International, Genzyme, a Sanofi Company and 77 others.
2026 Ulcerative Colitis Research Landscape
As of July 2026, the ulcerative colitis clinical trial landscape includes 100 actively recruiting studies across 195 cities in the United States. These studies are collectively seeking 249,647 participants, with an average enrollment target of 2,496 per study.
The research spans multiple phases of development: 23 studies are in NA, 19 studies are in PHASE3, 8 studies are in PHASE2, 3 studies are in PHASE4, 2 studies are in PHASE1. The presence of Phase 3 trials indicates that some ulcerative colitis treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 80 different organizations, including COPD Foundation, BioDelivery Sciences International, Genzyme, a Sanofi Company, The Duchenne Registry, University of Pittsburgh, and 75 others. The large number of sponsors reflects significant research interest and investment in ulcerative colitis treatment advancement.
Geographically, ulcerative colitis trials are most concentrated in New York, New York (14 trials); Philadelphia, Pennsylvania (13 trials); Little Rock, Arkansas (9 trials); San Francisco, California (9 trials); Chicago, Illinois (9 trials) and 7 other cities.
Featured Ulcerative Colitis Studies
Highlighted recruiting studies for ulcerative colitis, selected by enrollment size and research scope.
COPD Patient-Powered Research Network
The COPD Patient-Powered Research Network (COPD PPRN) is a patient research registry with the goal of enrolling 75,000 or more COPD patients and those at risk who are willing to share their heath information over several years and participate in research. The COPD PPRN has built an online platform to allow volunteers to enroll electronically, complete surveys, be contacted about studies they quali...
Risk of Major Adverse Cardiovascular Events for Naldemedine & Other Medications for Opioid Induced Constipation
The research objective is to characterize the risk of a major adverse cardiovascular event (MACE) among new users of naldemedine versus new users of lubiprostone and new users of naloxegol as comparator opioid induced constipation (OIC) medications.
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry
The ICGG Gaucher Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Gaucher disease, irrespective of treatment status. No experimental intervention is involved; patients in the Registry undergo clinical assessments and receive care as determined by the patient's treating physician. The objectives of the Re...
Frequently Asked Questions About Ulcerative Colitis Clinical Trials
Are there ulcerative colitis clinical trials near me?
Yes, there are 100 ulcerative colitis clinical trials currently recruiting across 195+ cities in the United States, including New York, New York; Philadelphia, Pennsylvania; Little Rock, Arkansas. Browse the studies above to find one at a location convenient for you.
How do I join a ulcerative colitis clinical trial?
To join a ulcerative colitis clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are ulcerative colitis clinical trials free?
Yes, participation in ulcerative colitis clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of ulcerative colitis treatments are being studied?
Current ulcerative colitis clinical trials are testing a range of approaches across NA (23 studies), PHASE3 (19 studies), PHASE2 (8 studies), PHASE4 (3 studies), PHASE1 (2 studies). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 80 research organizations.
Is it safe to participate in ulcerative colitis clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 18, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 18, 2026 · Data from ClinicalTrials.gov